 "Aurobindo Pharma finalizes acquisition of GLS Pharma, enhancing its oncology portfolio, gaining full ownership by December 2024.")
Aurobindo Pharma finalizes acquisition of GLS Pharma, enhancing its oncology portfolio, gaining full ownership by December 2024.
Aurobindo Pharma Ltd has announced its plan to acquire the remaining 49 percent stake in GLS Pharma Ltd for Rs 22.5 crore, making GLS a wholly-owned subsidiary. This agreement, finalized on September 18, 2024, involves purchasing 5,90,361 equity shares at Rs 381.12 per share. Aurobindo initially acquired a 51 percent stake in GLS from Suresh ...
